ATHEROSCLEROTIC VASCULAR DISEASE
Clinical trials for ATHEROSCLEROTIC VASCULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC VASCULAR DISEASE trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC VASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to boost statin use with simple doctor nudges
Disease control OngoingThis study tests two methods to increase referrals to a centralized pharmacy service for managing statin therapy in patients with or at high risk for heart disease. One method sends reminders to doctors during office visits, and the other sends electronic messages outside of visi…
Matched conditions: ATHEROSCLEROTIC VASCULAR DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Matched conditions: ATHEROSCLEROTIC VASCULAR DISEASE
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Real-World study tracks cholesterol drug inclisiran in heart patients
Knowledge-focused OngoingThis observational study follows about 198 patients in Spain who are already taking inclisiran (Leqvio) for high cholesterol linked to heart disease or a genetic condition. Researchers will check if patients reach their LDL cholesterol goals after 6 and 12 months. The goal is to …
Matched conditions: ATHEROSCLEROTIC VASCULAR DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Gene test could predict heart attack and stroke risk
Knowledge-focused OngoingThis study examines whether a common gene variation (CYP2C19) influences the long-term risk of serious heart and blood vessel events, such as heart attacks, strokes, and limb problems, in people with vascular disease. Researchers will analyze genetic and health data from 13,000 p…
Matched conditions: ATHEROSCLEROTIC VASCULAR DISEASE
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC